TABLE 1.
Demographic and surgical parameters of the CY‐ROC trial.
Parameters | Total cohort | Pneumoperitoneum pressures | |||
---|---|---|---|---|---|
12 mmHg | 15 mmHg | P * | |||
N | 20 | 10 | 10 | – | |
Gender | F (30.0%) | F (40.0%) | F (20.0%) | 0.628 c | |
M (70.0%) | M (60.0%) | M (80.0%) | |||
Age (years) a | 65 (50–75) | 63 (50–73) | 69 (50–75) | 0.089 b | |
BMI (kg m−2) a | 28 (22–34) | 27 (22–31) | 29.5 (23–34) | 0.315 b | |
Charlson score | 0 (70.0%) | 0 (70.0%) | 0 (70.0%) | 0.582 c | |
1 (20.0%) | 1 (10.0%) | 1 (30.0%) | |||
2 (5.0%) | 2 (10.0%) | ||||
3 (5.0%) | 3 (10.0%) | ||||
ASA grade | 1 (20.0%) | 1 (30.0%) | 1 (10.0%) | 0.582 c | |
2 (80.0%) | 2 (70.0%) | 2 (90.0%) | |||
Op time (min) a | 240 (200–400) | 240 (200–300) | 280 (210–400) | 0.143 b | |
Blood loss (mL) a | 50 (10–100) | 50 (10–100) | 30 (15–100) | 0.393 b | |
Blood transfusion intraoperatively or postoperatively | 0 | 0 | 0 | 0 | |
Passed flatus (post‐op day) a | 2 (1–7) | 2 (1–7) | 3 (2–4) | 0.393 b | |
Passed stools (post‐op day) a | 5.5 (4–11) | 5 (4–11) | 6.5 (3–10) | 0.684 b | |
Ileus (%) | 4 (19.0%) | 1 (10.0%) | 3 (30%) | 0.291 c | |
LOS (day) a | 9 (6–17) | 8 (6–17) | 9 (7–17) | 0.218 b | |
Readmission ≤90 days | No (90.0%) | No (80.0%) | No (80.0%) | 0.709 c | |
Yes (10.0%) | Yes (20.0%) | Yes (20.0%) | |||
Clavien–Dindo grading | 0 (90.0%) | 0 (80.0%) | 0 (80.0%) | 0.709 c | |
2 (10.0%) | 2 (20.0%) | 2 (20.0%) |
Abbreviations: ASA, American Society of Anaesthesiologists; BMI, body mass index; F, female; LOS, length of stay; M, male.
Median.
Kruskal–Wallis test.
χ 2 test.
P value significant at <0.05.